Mylanta vs Maalox: Which Antacid Is Actually Better for Acid Reflux and Gas?
By James H. Sterling
The origin of these household antacids traces back to mid-twentieth-century clinical pharmacology. Physicians needed an oral compound that could buffer harsh gastric hydrochloric acid without triggering metabolic alkalosis or dangerous bowel spasms. Sodium bicarbonate worked quickly, but it spiked systemic blood pressure and sparked uncomfortable acid rebound. The solution emerged through combining two complementary metal salts: aluminum hydroxide, which slows intestinal transit and induces constipation, and magnesium hydroxide, a fast-acting osmotic agent that loosens stools.
When mixed in precise therapeutic proportions, aluminum and magnesium neutralize each other's worst gastrointestinal side effects while sustaining an alkaline barrier. Maalox, its name an explicit portmanteau of magnesium and aluminum, built an international following around this pharmacological balance. Mylanta entered the commercial market with a similar base, but carved out a market niche by adding simethicone, an inert surfactant designed to coalesce tiny trapped intestinal gas bubbles into larger pockets that patients can easily expel.
The landscape shifted significantly in the 2010s. Novartis encountered manufacturing halts and product recalls at its Lincoln, Nebraska production facility, taking classic liquid Maalox off North American retail shelves for extended periods. In the aftermath, brand owners reformulated different versions. In many US drugstores today, products branded as Maalox appear as calcium carbonate chewables, whereas Mylanta, revived under Infirst Healthcare, redoubled its commitment to the classic liquid antacids comparison model. Knowing which formulation sits on your pharmacy shelf is the primary step toward selecting an effective treatment.
James Sterling reports on renewable energy developments, climate policy, ecological conservation, and green tech innovations around the globe.
